Aro Biotherapeutics Co reported raising $5 Million in an initial SEC Form D filing, from an offering of $5 Million
Amount Raised
$5 Million
Round Type
Venture
Quick answer
Aro Biotherapeutics raised $5 Million in a funding round, dated January 6, 2020. Aro Biotherapeutics is based in Philadelphia, Pennsylvania, United States.
- How much did Aro Biotherapeutics raise?
- Aro Biotherapeutics raised $5 Million in a funding round on January 6, 2020.
- What does Aro Biotherapeutics do?
- Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
- Where is Aro Biotherapeutics based and how big is it?
- Aro Biotherapeutics is based in Philadelphia, Pennsylvania, United States. Fundz records about 49 employees.
- Who are the decision-makers at Aro Biotherapeutics?
- Fundz holds 1 contact at Aro Biotherapeutics, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Aro Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Marina Biotech, Inc. raised $500K (Seed) on February 19, 2020.
- DermTech, Inc. raised $182K (Pre-Seed) on February 19, 2020.
- TearClear Corp. raised $2.8M (Seed) on February 14, 2020.
- JenaValve raised $35M on February 13, 2020.
- Helaina Inc raised $360K (Seed) on February 11, 2020.
- PRECIGEN, INC. raised $35M on February 11, 2020.
Who to call at Aro Biotherapeutics, and when
A new round usually means Aro Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aro Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aro Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aro Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aro Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aro Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.